Pyridine → HCID 68891743、化合物

HRID 2220222ノート

反応式

HRID 2220222 の反応式
[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[CH2:12][NH:11][C:10]3[CH:13]=[CH:14][C:15]([Cl:17])=[CH:16][C:9]=3[CH:8]=[CH:7][C:6]=2[CH:18]=1.N1C=CC=CC=1.[N:25]1([S:31](Cl)(=[O:33])=[O:32])[CH2:30][CH2:29][O:28][CH2:27][CH2:26]1>ClC(Cl)C>[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[CH2:12][N:11]([S:31]([N:25]3[CH2:30][CH2:29][O:28][CH2:27][CH2:26]3)(=[O:33])=[O:32])[C:10]3[CH:13]=[CH:14][C:15]([Cl:17])=[CH:16][C:9]=3[CH:8]=[CH:7][C:6]=2[CH:18]=1

参加物

5

反応物 3

HCID 1049PyridineHCID 12798265Morpholine-4-sulfonyl chlorideHCID 68893382HCID 68893382、化合物

生成物 1

HCID 68891743HCID 68891743、化合物収率 75.7%

試薬・触媒・溶媒 1

HCID 63651,1-Dichloroethane溶媒

反応条件

温度
100 °C

実験手順

A solution of 9-Bromo-2-chloro-5,6-dihydro-dibenzo[b,f]azocine (30 mg, 0.09 mmol) (prepared in a manner analogous to that described for Example 1F) in dichloroethane was treated with pyridine (0.02 mL, 0.27 mmol) and morpholine-4-sulfonyl chloride (22 mg, 0.12 mmol). The reaction mixture was stirred at 100° C. for four hours then concentrated, diluted with MeOH and filtered. The crude product was purified by preparative reversed-phase HPLC to afford Example 338A (32 mg). HPLC Rt=3.89 min. m/z=469 (M+H+)

後処理

  1. concentrationthen concentrated
  2. additiondiluted with MeOH
  3. filtrationfiltered
  4. customThe crude product was purified by preparative reversed-phase HPLC

出典と根拠

ORDレコード
ord-a78e161acb7444cf840432e63cd8616a
出典データセット
uspto-grants-2008_08
特許番号
US07417040B2

反応ノート

読み込み中…